Related content

Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer

By Kim Young  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 342-350

Humana Press, Inc

Access to resources Recommend Favorite

Small-Cell Lung Cancer in the Elderly: Is Age of Patient a Relevant Factor?

By Jara Carlos   Gómez-Aldaraví Jose L.   Tirado Raimundo   Meseguer Victoria A.   Alonso Carmen   Fernández Antonio  

Acta Oncologica, Vol. 38, Iss. 6, 1999-09 ,pp. : 781-786

Informa Healthcare

Access to resources Recommend Favorite

Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small-cell lung cancer

By Oka M.   Fukuda M.   Kuba M.   Ichiki M.   Rikimaru T.   Soda H.   Tsurutani J.   Nakamura Y.   Kawabata S.   Nakatomi K.   Narasaki F.   Nagashima S.   Takatani H.   Fukuda M.   Kinoshita A.   Kohno S.  

European Journal of Cancer, Vol. 38, Iss. 15, 2002-10 ,pp. : 1998-2004

Elsevier

Access to resources Recommend Favorite

A phase II study of dose-intensified weekly concomitant administration of cisplatin and irinotecan in chemonaive patients with extensive-disease small-cell lung cancer

By Han Ji-Youn   Lee Dae   Lee Sung   Park Chun   Kim Hae   Kim Eun-A   Yoon Sung   Lee Hong   Lee Jin  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 281-290

Humana Press, Inc

Access to resources Recommend Favorite

Ten years of disease-free survival between two diagnoses of small-cell lung cancer: A case report and a literature review

By Al-Ajam M.   Seymour A.   Mooty M.   Leaf A.  

Medical Oncology, Vol. 22, Iss. 1, 2005-03 ,pp. : 89-97

Humana Press, Inc

Access to resources Recommend Favorite